Please login to the form below

Not currently logged in
Email:
Password:

Pacira CEO David Stack joins board of health monitoring firm Medivo

Has also spent time at The Medicines Company, Innovex and Roche

David Stack, president and CEO of Pacira Pharmaceuticals has joined the board of Medivo, a US-based health monitoring firm for physicians and patients.

With more than 30 years' senior experience in the life scienes industry, Stack will work with Medivo as it aims to utilise new technology to collect clinical data from labs, and symptom data from apps and devices to help physicians provide better care and help their patients more effectively monitor their health.

“Dave is an experienced and respected leader in the life sciences industry and he brings a vast amount of insight and knowledge about healthcare to our board,” said Sundeep Bhan, CEO and co-founder of Medivo.

“We expect Dave to be a tremendous asset to Medivo's strategic team.”

Stack has been in his position at specialty pharma company Paciro since 2007, and is also the founding partner of Stack Pharmaceuicals – a commercialisation, marketing and strategy firm that serves emerging healthcare companies.

Prior to his time at Paciro, he was president and CEO of The Medicines Company, and president and general manager of Innovex.

He has also held senior positions at Immunomedics and Roche.

“This is a perfect time for me to reconnect with Sundeep and his management team at Medivo,” Stack said.

“We first worked together several years ago and, given the unique business model they have established, I am excited about this opportunity to work with this team again and to help Medivo advance this new patient-care platform.”

27th July 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health offers a unique breadth and depth of experience, across everything from early stage product commercialisation, strategy and research,...

Latest intelligence

Online Physician Communities
Research finds doctors are optimistic about new diabetes drugs but concerned over rationing
New data from M3 Global Research shows that clinicians buy in to the effectiveness of new diabetes therapies. However, they are concerned about rationing and believe that more resources are...
McCann.jpg
The heart of the matter: Part Two
How is social media impacting publication planning?...
digital numbers
Seven steps to innovating your digital strategy
Dealing with digitally native HCPs...